logo

For the Inventor, By the Inventor

Carlsbad, CA, United States of America

Ru Zhou

This inventor holds 16 USPTO granted patents and 3 published patent applications and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Agouron Pharmaceuticals, Inc., Pfizer Corporation, Other. Active years: 2000-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ru Zhou. Retrieved from https://idiyas.com/inventor/ru-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 56.3

 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • San Diego, CA (US) (2010 - 2012)
  • Carlsbad, CA (US) (2000 - 2023)

Company Filing History:

goldMedal11 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents
silverMedal4 out of 4,488 
 
Pfizer Corporation
 patents
bronzeMedal1 out of 834,570 
Other
 patents

Years Active: 2000-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
HPK1 Inhibitors
Antipicornaviral Compounds
Heterocyclic Compounds
Pharmaceutical Compositions
Therapeutic Agents
Benzofused Derivatives
Indolyl-Urea Derivatives
Synthesis Materials
16 patents (USPTO):Explore Patents
1. 11684616 - Azalactam compounds as HPK1 inhibitors (2023-06-27),
2. 11142525 - Azalactam compounds as HPK1 inhibitors (2021-10-12),
3. 8119624 - Fused phenyl amido heterocyclic compounds (2012-02-21),
4. 7842713 - Fused phenyl amido heterocyclic compounds (2010-11-30),
5. 7115658 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase (2006-10-03),
6. 7045528 - Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use (2006-05-16),
7. 6995142 - Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis (2006-02-07),
8. 6906198 - Antipicornaviral compounds, their preparation and use (2005-06-14),
9. 6869962 - Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use (2005-03-22),
10. 6833456 - Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use (2004-12-21),
11. 6649639 - Antipicornaviral compounds, compositions containing them, and methods for their use (2003-11-18),
12. 6534530 - Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis (2003-03-18),
13. 6531452 - Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis (2003-03-11),
14. 6514997 - Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis (2003-02-04),
15. 6331554 - Antipicornaviral compounds, compositions containing them, and methods for their use (2001-12-18),

Title: The Innovative Journey of Ru Zhou

Introduction

Ru Zhou, an accomplished inventor based in Carlsbad, California, has made significant contributions to the field of pharmaceuticals with her innovative research and development. With a remarkable portfolio of 16 patents, she has become a key figure in the realm of drug discovery and development.

Latest Patents

Among her latest patents, Ru Zhou has developed azalactam compounds as HPK1 inhibitors. This invention relates to compounds described by a general Formula I. These compounds hold great potential in the treatment of various diseases, showcasing her ability to push the boundaries of current pharmaceutical therapies.

Career Highlights

Ru Zhou's career has been marked by her association with renowned companies such as Agouron Pharmaceuticals, Inc. and Pfizer Corporation. These affiliations have allowed her to leverage her research in high-impact environments, contributing to important advancements in the pharmaceutical industry.

Collaboration

Throughout her career, Ru has collaborated with notable colleagues, including Peter Scott Dragovich and Thomas Jay Prins. These partnerships have enhanced her innovation capacity, fostering an environment of shared knowledge and expertise in her research initiatives.

Conclusion

In summary, Ru Zhou stands out as a prolific inventor whose work has the potential to reshape the landscape of pharmaceutical treatments. Through her continuous dedication to research and collaboration, she exemplifies the spirit of innovation that drives progress in today's healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…